One-year data from a large real-world dataset provide reassurance that clinical outcomes with the new-generation LAA occlusion device for stroke prevention compare well with those from pivotal trials.
Left Atrial Appendage Closure Is Safe to Consider Even in the Very Elderly
In-hospital mortality following LAAC was no higher in patients aged 80 or older than in their younger counterparts, a large database analysis shows. We share insights on LAAC in this population from the Cleveland Clinic experience.
SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days
Interim data from a large real-world dataset provide reassurance about acute and subacute procedural outcomes with the new-generation LAA occlusion device for stroke prevention.
Insights From 1,000+ Left Atrial Appendage Closure Procedures With Watchman
Our world-leading experience in this procedure confirms that it reduces stroke risk in high-risk patients and can be safely combined with TAVR as well as atrial fibrillation ablation.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Launching an LAAO Program: How Cleveland Clinic Assisted an Affiliated Institution
This case study details how a Missouri medical center quickly turned a site visit to Cleveland Clinic into a full-fledged program for left atrial appendage occlusion, with 25 procedures done within the first year.
Left Atrial Appendage Closure Device Found Safe and Effective for AF Despite Prior ICH
Patients with a history of intracranial hemorrhage have had few safe treatment options for nonvalvular atrial fibrillation. A new study of the Watchman device suggests that may be changing.
Watchman in the Real World: Reports on Use in High-Risk Patients and Overall Safety
Findings from three Cleveland Clinic real-world studies suggest a wider range of patients stand to benefit from the left atrial appendage closure device.
Options Expanding for Patients Who Require Anticoagulation
New anticoagulants and a new occlusive device are broadening the options for stroke prevention in patients who are at increased risk for clotting. For now, though, many still use warfarin.